---
title: "Immunic to Participate in Investor, Industry and Scientific Conferences in June"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289314021.md"
description: "On June 10, 2026, Immunic, Inc. (Nasdaq: IMUX), a leading biotech firm focusing on advanced oral treatments for neurologic disorders, disclosed its involvement in various investor, industry, and scientific conferences happening this month. The company's participation in these events highlights its commitment to advancing medical innovation and sharing insights within the field. This aligns with Immunic's mission to address the unmet medical needs of patients. Through these engagements, Immunic aims to showcase its potential in transforming the treatment landscape for neurologic diseases."
datetime: "2026-06-10T10:33:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289314021.md)
  - [en](https://longbridge.com/en/news/289314021.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289314021.md)
---

# Immunic to Participate in Investor, Industry and Scientific Conferences in June

On June 10, 2026, Immunic, Inc. (Nasdaq: IMUX), a leading biotech firm focusing on advanced oral treatments for neurologic disorders, disclosed its involvement in various investor, industry, and scientific conferences happening this month. The company's participation in these events highlights its commitment to advancing medical innovation and sharing insights within the field. This aligns with Immunic's mission to address the unmet medical needs of patients. Through these engagements, Immunic aims to showcase its potential in transforming the treatment landscape for neurologic diseases.

### Related Stocks

- [IMUX.US](https://longbridge.com/en/quote/IMUX.US.md)

## Related News & Research

- [Immunic Updates Corporate Strategy, Highlights Vidofludimus Plans](https://longbridge.com/en/news/292732048.md)
- [08:20 ETEbix Health Expands Medical Content and Coding Capabilities](https://longbridge.com/en/news/294206575.md)
- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [Kazia Therapeutics Files Provisional Patent Backing New Paxalisib Strategy in High-Risk Early TNBC](https://longbridge.com/en/news/294061781.md)
- [Novanta completes acquisition of Riverpoint Medical](https://longbridge.com/en/news/293928249.md)